The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from CNW Group

Atrium Innovations Announces an Increase of its Normal Course Issuer Bid

Tuesday, March 20, 2012

Atrium Innovations Announces an Increase of its Normal Course Issuer Bid11:24 EDT Tuesday, March 20, 2012QUEBEC CITY, March 20, 2012 /CNW Telbec/ - Atrium Innovations Inc. (TSX: ATB) announced today that it has filed with the Toronto Stock Exchange ("TSX"), and the TSX has accepted, a revised version of the Notice of Intention to make a Normal Course Issuer Bid which was initially filed on November 9, 2011 for the purpose of increasing the number of common shares that can be purchased thereunder. The increase will be effective as of March 22, 2012.  Under its normal course issuer bid, as revised, Atrium intends to purchase up to 2,353,756 of its common shares, representing 10% of its public float as of October 31, 2011, comprised of 23,537,566 common shares. This represents an increase of 1,539,786 common shares from the initial number of shares previously announced on November 9, 2011. The average daily trading volume for the 6-month period preceding October 31, 2011 represents 31,531 common shares.  In accordance with the TSX requirements, a maximum daily purchase of the greater of 25% of this average or 1,000 shares may be made, which represents a total of 7,882 common shares.Purchases will be made on the open market by Atrium through the facilities of the TSX.  The purchases had commenced on November 15, 2011 and will terminate on November 14, 2012, or on such earlier date as Atrium will have completed its purchases pursuant to the Notice of Intention to make a Normal Course Issuer Bid filed with the TSX.  Atrium will cancel any common shares purchased pursuant to the normal course issuer bid. Atrium will pay the market price of common shares on the TSX at the time of purchase and no purchases of common shares will be made other than open-market purchases.Atrium considers that repurchasing its common shares is a sound business and financial decision as shares in circulation will be reduced and the proportionate interest of all remaining shareholders in the share capital of Atrium will be increased on a pro rata basis.No appraisal or valuation regarding Atrium, its material assets or securities was prepared within the two years preceding the date of the Notice of Intention to make a Normal Course Issuer Bid.About AtriumAtrium Innovations Inc. is a globally-recognized leader in the development, manufacturing, and commercialization of innovative, science-based dietary supplements endorsed by health professionals. The Company distributes its extensive portfolio of products mainly in the healthcare practitioner and health food and specialized store channels, with a primary focus in North America and Europe. Atrium is at the forefront of science, innovation and education in the dietary supplement industry.  The Company has over 1,100 employees and operates eight manufacturing facilities. Additional information is available at www.atrium-innovations.com.Cautionary Note and Forward-Looking StatementsThis press release contains certain forward-looking statements with respect to the Company. These forward-looking statements, by their nature, require the Company to make certain assumptions and necessarily involve known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied in these forward-looking statements. Forward-looking statements are not guarantees of performance. These forward-looking statements, including financial outlooks, may involve, but are not limited to, comments with respect to the Company's business or financial objectives, its strategies or future actions, its targets, expectations for financial condition or outlook for operations and future contingent payments. Words such as "may", "will", "would", "could", "expect", "believe", "plan", "anticipate", "intend", "estimate", "continue", or the negative or comparable terminology, as well as terms usually used in the future and the conditional, are intended to identify forward-looking statements. Information contained in forward-looking statements is based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including management's perceptions of historical trends, current conditions and expected future developments, as well as other considerations that are believed to be appropriate in the circumstances.  The Company considers these assumptions to be reasonable based on information currently available to it, but cautions the reader that these assumptions regarding future events, many of which are beyond its control, may ultimately prove to be incorrect since they are subject to risks and uncertainties that affect the Company and its business. For additional information with respect to these and other factors and assumptions underlying the forward-looking statements made in this press release, see the Company's quarterly and annual Management Discussion and Analysis for the fiscal year ended December 31, 2010 filed with the Canadian securities commissions. The forward-looking information set forth herein reflects the Company's expectations as at the date of this press release and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, other than as required by law.For further information: Investor Relations:  Mario Paradis Vice President and Chief Financial Officer Tel.: 418 652-1116  mp@atrium-innovations.com Pierre Boucher MaisonBrison Communications Tel.: 514 731-0000, ext. 237 pierre@maisonbrison.comMedia Relations: Amélie Germain Director of Communications Tel.: 418 652-1116  ag@atrium-innovations.com